Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

29 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been shown to have a beneficial impact on heart failure related outcomes. Regardless, a high residual event rate is to be noted.

In our pilot study, we wished to document whether a clinical pharmacist could still play a role in the heart failure management of an elderly inpatient heart failure population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison

NCT01002456

Heart Failure

COMPLETED NA

PHARM Optimal-HF Pilot

NCT05623358

Heart Failure With Reduced Ejection Fraction

ACTIVE_NOT_RECRUITING NA

Community Pharmacy Medication Therapy Management for Heart Failure

NCT03608085

Heart Failure

UNKNOWN NA

Pharmacist Role in HF Patients Transition of Care

NCT02874183

Heart Failure

WITHDRAWN NA

Risk and Benefit Informed MTM Pharmacist Intervention in Heart Failure

NCT03804606

Heart Failure

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

clinical pharmacy intervention

Group Type EXPERIMENTAL

heart-failure related pharmaceutical intervention

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

heart-failure related pharmaceutical intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 75 years or older
* diagnosis of previous or new heart failure based on signs and symptoms as defined by the 'European Society of Cardiology guidelines on acute and chronic heart failure'
* diagnosis had to be confirmed by a recent echocardiogram